CV Advisors’s Astera Labs ALAB Stock Holding History

CV Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,000	Closed	-$333K	–	54
2025 Q4	$333K	Hold	2,000	–	–	0.08%	38
2025 Q3	$392K	Buy	+2,000	New	+$329K	0.11%	37
2025 Q1	–	Sell	-2,000	Closed	-$265K	–	44
2024 Q4	$265K	Buy	+2,000	New	+$188K	0.09%	26

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

CV Advisors's ALAB Position: Q1 2026 in Review

CV Advisors sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 2,000 shares — an estimated $333K sold.

CV Advisors first reported a position in ALAB in Q4 2024 and held it in 3 quarters. The position peaked at $392K in Q3 2025. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

CV Advisors reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
CV Advisors sold 2,000 Astera Labs shares in Q1 2026, an estimated $333K.
CV Advisors first reported a position in Astera Labs in Q4 2024 and held it in 3 quarters.
CV Advisors's Astera Labs position peaked at $392K in Q3 2025.
708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on CV Advisors's 13F filing for Q1 2026, filed 1 May 2026.